SCHEMBL29254424

SCHEMBL29254424

COc1cccc2c1ncc1cn[nH]c12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.54
▸ HPGD P15428 2/20 0.54
▸ KDM4E B2RXH2 1/20 0.54
▸ HPGDS O60760 1/20 0.44
▸ RET P07949 1/20 0.44
▸ HTR1A P08908 2/20 0.42
▸ ADRA1D P25100 2/20 0.42
▸ ADRA1A P35348 2/20 0.42
▸ ADRA1B P35368 2/20 0.42
▸ ABL1 P00519 1/20 0.42
▸ RAD52 P43351 1/20 0.42
▸ RIN1 Q13671 1/20 0.42
▸ GABRP O00591 1/20 0.42
▸ GABRD O14764 1/20 0.42
▸ GABRA1 P14867 1/20 0.42
▸ GABRB1 P18505 1/20 0.42
▸ GABRG2 P18507 1/20 0.42
▸ GABRB3 P28472 1/20 0.42
▸ GABRA5 P31644 1/20 0.42
▸ GABRA3 P34903 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30345130 1.00 ALDH1A1 (0.54) ALDH1A1HPGDKDM4EHPGDSRET
SCHEMBL10595701 0.78 ALDH1A1 (0.56) ALDH1A1HPGDKDM4ERETABL1
SCHEMBL5483794 0.77 HPGD (0.62) ALDH1A1HPGDKDM4ERETITK
SCHEMBL12463180 0.76 HPGDS (0.54) ALDH1A1HPGDKDM4EHPGDSHTR1A
SCHEMBL29254453 0.74 ATP4A (0.41) ALDH1A1HPGDKDM4EHPGDSHTR1A
SCHEMBL1661234 0.73 TRPA1 (0.40) HPGDKDM4EMAPTHSD17B10
SCHEMBL5583144 0.72 KDM4E (0.56) ALDH1A1HPGDKDM4ERETNQO2
SCHEMBL1552041 0.70 ALDH1A1 (1.00) ALDH1A1HPGDKDM4EABL1RAD52
SCHEMBL16132474 0.69 CCR1 (0.57) HPGDSHTR1AADRA1DADRA1AADRA1B
SCHEMBL30951512 0.69 PDE4A (0.54) ALDH1A1KDM4EHPGDSRETITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250011319-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF LOMOND THERAPEUTICS, INC. 2025-01-09 — — US claimed
CN-118076605-A Substituted 1H-pyrazolo [4,3-c ] quinolines, methods of preparation and uses thereof 洛蒙治疗公司 2024-05-24 — — CN claimed
US-20250011319-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF LOMOND THERAPEUTICS, INC. 2025-01-09 — — US disclosed
CN-118076605-A Substituted 1H-pyrazolo [4,3-c ] quinolines, methods of preparation and uses thereof 洛蒙治疗公司 2024-05-24 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250011319-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF FLT3, PDXK, PHKG1 ALDH1A1 2059/4885HPGD 683/4885KDM4E 2039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback